A Small Molecule that Promotes Cardiac Differentiation of Human Pluripotent Stem Cells under Defined, Cytokine- and Xeno-free Conditions

Cell Reports

Volumn 2, Issue 5, 2012, Pages 1448-1460

  Minami, Itsunari ^a   Yamada, Kohei ^a,b,f   Otsuji, Tomomi G ^a,c   Yamamoto, Takuya ^a,d   Shen, Yan ^a,b   Otsuka, Shinya ^a,b   Kadota, Shin ^a,b   Morone, Nobuhiro ^a   Barve, Maneesha ^a   Asai, Yasuyuki ^e   Tenkova Heuser, Tatyana ^a   Heuser, John E ^a   Uesugi, Motonari ^a,b   Aiba, Kazuhiro ^a   Nakatsuji, Norio ^a,c  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e ReproCELL Inc   (Japan)

^f KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; BONE MORPHOGENETIC PROTEIN 4; CYTOKINE; INSULIN; KY 02111; N 11474; PROTEIN INHIBITOR; RECOMBINANT CYTOKINE; TROPONIN T; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANONICAL ANALYSIS; CELL DIFFERENTIATION; DRUG MECHANISM; EMBRYONIC STEM CELL; HAPLORHINI; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; WNT SIGNALING PATHWAY;

ANIMALS; BENZOTHIAZOLES; CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; HAPLORHINI; HEK293 CELLS; HUMANS; MYOCYTES, CARDIAC; PHENYLPROPIONATES; PLURIPOTENT STEM CELLS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84870421675     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2012.09.015     Document Type: Article

References (48)

1. Asai Y., Tada M., Otsuji T.G., Nakatsuji N. Combination of functional cardiomyocytes derived from human stem cells and a highly-efficient microelectrode array system: an ideal hybrid model assay for drug development. Curr. Stem Cell Res. Ther. 2010, 5:227-232.
2. Burridge P.W., Thompson S., Millrod M.A., Weinberg S., Yuan X., Peters A., Mahairaki V., Koliatsos V.E., Tung L., Zambidis E.T. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One 2011, 6:e18293.
3. Burridge P.W., Keller G., Gold J.D., Wu J.C. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell 2012, 10:16-28.
4. Chen B., Dodge M.E., Tang W., Lu J., Ma Z., Fan C.W., Wei S., Hao W., Kilgore J., Williams N.S., et al. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat. Chem. Biol. 2009, 5:100-107.
5. Chien K.R., Moretti A., Laugwitz K.L. Development. ES cells to the rescue. Science 2004, 306:239-240.
6. Chien K.R., Domian I.J., Parker K.K. Cardiogenesis and the complex biology of regenerative cardiovascular medicine. Science 2008, 322:1494-1497.
7. Dubois N.C., Craft A.M., Sharma P., Elliott D.A., Stanley E.G., Elefanty A.G., Gramolini A., Keller G. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat. Biotechnol. 2011, 29:1011-1018.
8. Gotea V., Ovcharenko I. DiRE: identifying distant regulatory elements of co-expressed genes. Nucleic Acids Res. 2008, 36(Web Server issue):W133-W139.
9. Graichen R., Xu X., Braam S.R., Balakrishnan T., Norfiza S., Sieh S., Soo S.Y., Tham S.C., Mummery C., Colman A., et al. Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation 2008, 76:357-370.
10. Hansson E.M., Lindsay M.E., Chien K.R. Regeneration next: toward heart stem cell therapeutics. Cell Stem Cell 2009, 5:364-377.
11. Hao J., Daleo M.A., Murphy C.K., Yu P.B., Ho J.N., Hu J., Peterson R.T., Hatzopoulos A.K., Hong C.C. Dorsomorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells. PLoS One 2008, 3:e2904.
12. Hattori F., Chen H., Yamashita H., Tohyama S., Satoh Y.S., Yuasa S., Li W., Yamakawa H., Tanaka T., Onitsuka T., et al. Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat. Methods 2010, 7:61-66.
13. Ichida J.K., Blanchard J., Lam K., Son E.Y., Chung J.E., Egli D., Loh K.M., Carter A.C., Di Giorgio F.P., Koszka K., et al. A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell 2009, 5:491-503.
14. Irion S., Nostro M.C., Kattman S.J., Keller G.M. Directed differentiation of pluripotent stem cells: from developmental biology to therapeutic applications. Cold Spring Harb. Symp. Quant. Biol. 2008, 73:101-110.
15. Jacot J.G., Martin J.C., Hunt D.L. Mechanobiology of cardiomyocyte development. J. Biomech. 2010, 43:93-98.
16. Kamisuki S., Mao Q., Abu-Elheiga L., Gu Z., Kugimiya A., Kwon Y., Shinohara T., Kawazoe Y., Sato S., Asakura K., et al. A small molecule that blocks fat synthesis by inhibiting the activation of SREBP. Chem. Biol. 2009, 16:882-892.
17. Kattman S.J., Witty A.D., Gagliardi M., Dubois N.C., Niapour M., Hotta A., Ellis J., Keller G. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 2011, 8:228-240.
18. Laflamme M.A., Murry C.E. Heart regeneration. Nature 2011, 473:326-335.
19. Lian X., Hsiao C., Wilson G., Zhu K., Hazeltine L.B., Azarin S.M., Raval K.K., Zhang J., Kamp T.J., Palecek S.P. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc. Natl. Acad. Sci. USA 2012, 109:E1848-E1857.
20. Lutolf M.P., Gilbert P.M., Blau H.M. Designing materials to direct stem-cell fate. Nature 2009, 462:433-441.
21. Menasché P. Stem cell therapy for heart failure: are arrhythmias a real safety concern?. Circulation 2009, 119:2735-2740.
22. Mignone J.L., Kreutziger K.L., Paige S.L., Murry C.E. Cardiogenesis from human embryonic stem cells. Circ. J. 2010, 74:2517-2526.
23. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., Kinzler K.W. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997, 275:1787-1790.
24. Mummery C.L., Zhang J., Ng E.S., Elliott D.A., Elefanty A.G., Kamp T.J. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ. Res. 2012, 111:344-358.
25. Murakami G., Inoue H., Tsukita K., Asai Y., Amagai Y., Aiba K., Shimogawa H., Uesugi M., Nakatsuji N., Takahashi R. Chemical library screening identifies a small molecule that downregulates SOD1 transcription for drugs to treat amyotrophic lateral sclerosis. J. Biomol. Screen. 2011, 16:405-414.
26. Naito A.T., Shiojima I., Akazawa H., Hidaka K., Morisaki T., Kikuchi A., Komuro I. Developmental stage-specific biphasic roles of Wnt/beta-catenin signaling in cardiomyogenesis and hematopoiesis. Proc. Natl. Acad. Sci. USA 2006, 103:19812-19817.
27. Narwal M., Venkannagari H., Lehtiö L. Structural basis of selective inhibition of human tankyrases. J. Med. Chem. 2012, 55:1360-1367.
28. Osafune K., Caron L., Borowiak M., Martinez R.J., Fitz-Gerald C.S., Sato Y., Cowan C.A., Chien K.R., Melton D.A. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat. Biotechnol. 2008, 26:313-315.
29. Otsuji T.G., Minami I., Kurose Y., Yamauchi K., Tada M., Nakatsuji N. Progressive maturation in contracting cardiomyocytes derived from human embryonic stem cells: qualitative effects on electrophysiological responses to drugs. Stem Cell Res. (Amst.) 2010, 4:201-213.
30. Paige S.L., Osugi T., Afanasiev O.K., Pabon L., Reinecke H., Murry C.E. Endogenous Wnt/beta-catenin signaling is required for cardiac differentiation in human embryonic stem cells. PLoS One 2010, 5:e11134.
31. Passier R., van Laake L.W., Mummery C.L. Stem-cell-based therapy and lessons from the heart. Nature 2008, 453:322-329.
32. Qyang Y., Martin-Puig S., Chiravuri M., Chen S., Xu H., Bu L., Jiang X., Lin L., Granger A., Moretti A., et al. The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway. Cell Stem Cell 2007, 1:165-179.
33. Rajala K., Pekkanen-Mattila M., Aalto-Setälä K. Cardiac differentiation of pluripotent stem cells. Stem Cells Int. 2011, 2011:383709.
34. Ren Y., Lee M.Y., Schliffke S., Paavola J., Amos P.J., Ge X., Ye M., Zhu S., Senyei G., Lum L., et al. Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells. J. Mol. Cell. Cardiol. 2011, 51:280-287.
35. Sato A., Kawazoe Y., Kamisuki S., Uesugi M. Synthesis of synthetic small molecule transcription factors (STF). Nucleic Acids Symp. Ser. (Oxf) 2006, 50:29-30.
36. Segers V.F., Lee R.T. Stem-cell therapy for cardiac disease. Nature 2008, 451:937-942.
37. Suemori H., Nakatsuji N. Generation and characterization of monkey embryonic stem cells. Methods Mol. Biol. 2006, 329:81-89.
38. Suemori H., Yasuchika K., Hasegawa K., Fujioka T., Tsuneyoshi N., Nakatsuji N. Efficient establishment of human embryonic stem cell lines and long-term maintenance with stable karyotype by enzymatic bulk passage. Biochem. Biophys. Res. Commun. 2006, 345:926-932.
39. Suessbrich H., Waldegger S., Lang F., Busch A.E. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole. FEBS Lett. 1996, 385:77-80.
40. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
41. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
42. Wang H., Hao J., Hong C.C. Cardiac induction of embryonic stem cells by a small molecule inhibitor of Wnt/β-catenin signaling. ACS Chem. Biol. 2011, 6:192-197.
43. Willems E., Spiering S., Davidovics H., Lanier M., Xia Z., Dawson M., Cashman J., Mercola M. Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm. Circ. Res. 2011, 109:360-364.
44. Xu Y., Shi Y., Ding S. A chemical approach to stem-cell biology and regenerative medicine. Nature 2008, 453:338-344.
45. Yang L., Soonpaa M.H., Adler E.D., Roepke T.K., Kattman S.J., Kennedy M., Henckaerts E., Bonham K., Abbott G.W., Linden R.M., et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 2008, 453:524-528.
46. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
47. Yuasa S., Itabashi Y., Koshimizu U., Tanaka T., Sugimura K., Kinoshita M., Hattori F., Fukami S., Shimazaki T., Ogawa S., et al. Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nat. Biotechnol. 2005, 23:607-611.
48. Zhu W., Shiojima I., Ito Y., Li Z., Ikeda H., Yoshida M., Naito A.T., Nishi J., Ueno H., Umezawa A., et al. IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis. Nature 2008, 454:345-349.